Xiaofang, et al. “Anti-Programmed Cell Death 1 or Anti-Programmed Cell Death Ligand 1 Vs. Sunitinib for the Management of Advanced Renal Cell Carcinoma ：a Meta-Analysis”. American Journal of Translational Medicine, vol. 7, no. 1, Mar. 2023, pp. 55-63, https://ajtm.journals.publicknowledgeproject.org/index.php/ajtm/article/view/2680.